June 18, Globe & Mail Centre, TO
Michael Stone is an executive leader in the healthcare industry, known for his strategic vision and innovative approach within the pharmaceutical and medical device sectors. With a career spanning over three decades, he has garnered a reputation for critically evaluating business opportunities, launching successful brands, and executing patient-centric solutions. Michael’s leadership style is marked by authenticity and trust, as he has consistently developed high-potential employees into successful leaders on both local and international stages. Michael has been recognized for his exceptional contributions, including the Global President’s Award for exceeding sales and profit plans in 2019 and 2020, and the Global Marketing Award for innovation in rheumatology marketing in 2016. He was also honored with the Lilly Canada Award of Excellence for outstanding contributions to the affiliate. Michael is committed to giving back to the community, serving as a head coach and assistant coach for local youth hockey teams from 2006 to 2019. He also chaired the United Way campaign at Eli Lilly Canada, raising over $90,000 to support community initiatives. With a passion for innovation and a proven track record of success, Michael Stone continues to make significant contributions to the healthcare landscape, driving meaningful change and fostering growth within the industry.
In a market overshadowed by rapid technological innovation, changing customer needs and increased complexity, commercial strategy is harder than ever. In this session to set the day’s scene, life science leaders will share their commercial bets for 2027, and what they are quietly walking away from.
